ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Episode 06: From Lab to Market: How Lifelines can help"
Episode Synopsis
Developing efficient and reliable production methods for new biological active ingredients is crucial, especially considering the significant demand for immunoglobulin IgG1 in medicine. What novel approaches are currently being explored to enhance the amount of producing biological active ingredients?
Join us in this episode as we engage with Prof. Dr. Ralf Takors from the University of Stuttgart and Prof. Dr. Michael Schlüter from TUHH. Together, we explore the challenges and innovations involved in scaling laboratory processes to industrial scales. Discover how this dedicated team of researchers is leading advancements in biotechnological strategies and how lifelines can be used for more information.
InterZell, funded by the DFG as a priority program (SPP 2170), focuses on cell-cell and cell-bioreactor interactions, bridging biological research with engineering principles in modern biochemical engineering. For more information, visit https://www.spp2170.uni-stuttgart.de/
Join us in this episode as we engage with Prof. Dr. Ralf Takors from the University of Stuttgart and Prof. Dr. Michael Schlüter from TUHH. Together, we explore the challenges and innovations involved in scaling laboratory processes to industrial scales. Discover how this dedicated team of researchers is leading advancements in biotechnological strategies and how lifelines can be used for more information.
InterZell, funded by the DFG as a priority program (SPP 2170), focuses on cell-cell and cell-bioreactor interactions, bridging biological research with engineering principles in modern biochemical engineering. For more information, visit https://www.spp2170.uni-stuttgart.de/
More episodes of the podcast Lab Whispers about Bioengineering
Episode 04: Turning Emissions into Solutions
07/10/2024
In God we trust